Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

• William R. Lumry,
• Bruce Zuraw,
• Marco Cicardi,
• Timothy Craig,
• John Anderson,
• Aleena Banerji,
• Jonathan A. Bernstein,
• Teresa Caballero,
• Henriette Farkas,
• Richard G. Gower,
• Paul K. Keith,
• Donald S. Levy,
• H. Henry Li,
• Markus Magerl,
• Michael Manning,
• Marc A. Riedl,
• John-Philip Lawo,
• Subhransu Prusty,
• Thomas Machnig,
• Hilary Longhurst,
• the COMPACT Investigators

Affiliations

William R. Lumry

AARA Research Center

Bruce Zuraw

Department of Medicine, UC San Diego

Marco Cicardi

University of Milan

Timothy Craig

Penn State University College of Medicine

John Anderson

Clinical Research Center of Alabama

Aleena Banerji

Massachusetts General Hospital

Jonathan A. Bernstein

University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC

Teresa Caballero

Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network On Rare Diseases (CIBERER U754)

Henriette Farkas

Hungarian Angioedema Reference Center, 3Rd Department of Internal Medicine, Semmelweis University

Richard G. Gower

Maryclif Clinical Research

Paul K. Keith

McMaster University

Donald S. Levy

UC Irvine

H. Henry Li

Institute for Asthma and Allergy

Markus Magerl

Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin

Michael Manning

Medical Research of Arizona

Marc A. Riedl

Division of Rheumatology, Allergy and Immunology, University of California, San Diego

John-Philip Lawo

CSL Behring GmbH

Subhransu Prusty

CSL Behring GmbH

Thomas Machnig

CSL Behring GmbH

Hilary Longhurst

University College Hospital

the COMPACT Investigators